{"id":3764,"date":"2022-08-02T09:30:47","date_gmt":"2022-08-02T01:30:47","guid":{"rendered":"https:\/\/regask.com\/?p=3764"},"modified":"2024-10-25T00:45:40","modified_gmt":"2024-10-24T16:45:40","slug":"%e3%82%aa%e3%83%bc%e3%82%b9%e3%83%88%e3%83%a9%e3%83%aa%e3%82%a2%e3%81%ae%e3%82%b3%e3%83%b3%e3%83%97%e3%83%a9%e3%82%a4%e3%82%a2%e3%83%b3%e3%82%b9%e5%84%aa%e5%85%88%e4%ba%8b%e9%a0%85-2022","status":"publish","type":"post","link":"https:\/\/regask.com\/ja\/australia-compliance-priorities-2022\/","title":{"rendered":"\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2: \u8f38\u5165\u3001\u5e83\u544a\u3001\u4f9b\u7d66\u306e\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9 \u30d7\u30ed\u2026"},"content":{"rendered":"

\u306e TGA<\/a> 2022\u5e747\u67081\u65e5\u304b\u30892023\u5e746\u670830\u65e5\u307e\u3067\u306e\u8f38\u5165\u3001\u5e83\u544a\u3001\u4f9b\u7d66\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u306e\u512a\u5148\u4e8b\u9805\u306e\u30ea\u30b9\u30c8\u3092\u516c\u958b\u3057\u307e\u3057\u305f\u3002<\/p>\n

    \n
  1. \u9055\u6cd5\u306a\u8f38\u5165\u3001\u5e83\u544a\u3001\u4f9b\u7d66\u3092\u963b\u6b62\u3057\u3001\u5bfe\u51e6\u3059\u308b COVID-19\u306b\u95a2\u9023\u3059\u308b\u672a\u627f\u8a8d\u306e\u6cbb\u7642\u7528\u54c1\u3002<\/strong><\/li>\n
  2. \u9055\u6cd5\u306a\u8f38\u5165\u3001\u5e83\u544a\u3001\u4f9b\u7d66\u3092\u963b\u6b62\u3057\u3001\u5bfe\u51e6\u3059\u308b \u30cb\u30b3\u30c1\u30f3\u5165\u308a\u96fb\u5b50\u30bf\u30d0\u30b3\u88fd\u54c1\u3002<\/strong><\/li>\n
  3. 1989\u5e74\u533b\u85ac\u54c1\u6cd5\u306e\u8981\u4ef6\u3092\u9075\u5b88\u3059\u308b\u3053\u3068\u3092\u78ba\u5b9f\u306b\u3059\u308b\u00a0\u533b\u7642\u7528\u5927\u9ebb\u7523\u696d<\/strong><\/li>\n
  4. \u9055\u6cd5\u306a\u8f38\u5165\u3001\u88fd\u9020\u3001\u5e83\u544a\u3001\u4f9b\u7d66\u3092\u963b\u6b62\u3057\u3001\u5bfe\u51e6\u3059\u308b \u30b9\u30dd\u30fc\u30c4\u30b5\u30d7\u30ea\u30e1\u30f3\u30c8\u3092\u542b\u3080\u3001\u672a\u627f\u8a8d\u306e\u30d1\u30d5\u30a9\u30fc\u30de\u30f3\u30b9\u5411\u4e0a\u304a\u3088\u3073\u30a4\u30e1\u30fc\u30b8\u5411\u4e0a\u6cbb\u7642\u5546\u54c1\u3001 <\/strong>\u30b9\u30b1\u30b8\u30e5\u30fc\u30eb 4 \u304a\u3088\u3073 8 \u306e\u6bd2\u7269\u3092\u542b\u3080\u88fd\u54c1\u306b\u91cd\u70b9\u3092\u7f6e\u3044\u3066\u3044\u307e\u3059\u3002<\/li>\n
  5. \u9055\u6cd5\u306a\u8f38\u5165\u3001\u5e83\u544a\u3001\u4f9b\u7d66\u3092\u963b\u6b62\u3057\u3001\u5bfe\u51e6\u3059\u308b \u7f8e\u5bb9\u304a\u3088\u3073\u7f8e\u5bb9\u6b6f\u79d1\u696d\u754c\u3067\u4f7f\u7528\u3055\u308c\u308b\u672a\u627f\u8a8d\u306e\u6cbb\u7642\u7528\u54c1\u3002<\/strong><\/li>\n
  6. \u5bfe\u51e6\u3059\u308b\u00a0\u5236\u9650\u304a\u3088\u3073\u7981\u6b62\u3055\u308c\u3066\u3044\u308b\u8868\u73fe\u306e\u9055\u6cd5\u306a\u4f7f\u7528\u00a0<\/strong>\u627f\u8a8d\u307e\u305f\u306f\u8a31\u53ef\u3055\u308c\u3066\u3044\u306a\u3044\u5e83\u544a\u3001\u7279\u306b\u8106\u5f31\u306a\u6d88\u8cbb\u8005\u3092\u30bf\u30fc\u30b2\u30c3\u30c8\u306b\u3057\u305f\u5e83\u544a\u3067\u306f\u3001<\/li>\n
  7. \u9055\u6cd5\u306a\u5e83\u544a\u3092\u6291\u6b62\u3057\u3001\u5bfe\u51e6\u3059\u308b\u00a0\u96fb\u5b50\u5546\u53d6\u5f15\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u4e0a\u306e\u672a\u627f\u8a8d\u6cbb\u7642\u7528\u5546\u54c1\u00a0<\/strong>\u598a\u5a20\u30fb\u51fa\u7523\u524d\u7528\u54c1\u3001\u6e1b\u91cf\u88fd\u54c1\u3001\u4e8c\u65e5\u9154\u3044\u6cbb\u7642\u85ac\u306a\u3069\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/li>\n<\/ol>\n
    \n
    \n
    \n
    \n

    \u9805\u76ee 4 \u306b\u95a2\u9023\u3057\u3066\u3001TGA \u306f\u672a\u627f\u8a8d\u88fd\u54c1\u306e\u8f38\u5165\u3001\u88fd\u9020\u3001\u5e83\u544a\u3001\u914d\u5408\u3001\u4f9b\u7d66\u306b\u91cd\u70b9\u3092\u7f6e\u304f\u3053\u3068\u3092\u63d0\u6848\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306b\u306f\u3001\u6d88\u8cbb\u8005\u6559\u80b2\u3068\u3001\u672a\u627f\u8a8d\u306e\u30b9\u30dd\u30fc\u30c4\u30b5\u30d7\u30ea\u30e1\u30f3\u30c8\u3092\u5ba3\u4f1d\u3059\u308b\u30aa\u30f3\u30e9\u30a4\u30f3 \u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u30bf\u30fc\u30b2\u30c6\u30a3\u30f3\u30b0\u304c\u4f34\u3044\u307e\u3059\u3002<\/p>\n

    \u9805\u76ee6\u306b\u95a2\u9023\u3057\u3066\u3001TGA\u306f\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u304c\u9069\u5fdc\u75c7\u306b\u95a2\u3059\u308b\u9069\u5207\u306a\u8a3c\u62e0\u3092\u4fdd\u6301\u3057\u3066\u304a\u3089\u305a\u3001\u9069\u5fdc\u75c7\u3092\u767b\u9332\u3057\u3066\u3044\u306a\u3044\u6df1\u523b\u306a\u75c5\u6c17\u3084\u75c7\u72b6\u306b\u95a2\u9023\u3059\u308b\u9055\u6cd5\u306a\u5e83\u544a\u306b\u7126\u70b9\u3092\u5f53\u3066\u307e\u3059\u3002\u00a0\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2<\/span>n \u533b\u85ac\u54c1\u767b\u9332\u7c3f\u3002<\/p>\n

    \u9805\u76ee 7 \u306b\u95a2\u9023\u3057\u3066\u3001TGA \u306f\u3001\u30aa\u30f3\u30e9\u30a4\u30f3 \u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u901a\u3058\u3066\u5ba3\u4f1d\u304a\u3088\u3073\u8ca9\u58f2\u3055\u308c\u3066\u3044\u308b\u672a\u627f\u8a8d\u306e\u88dc\u5b8c\u533b\u7642\u3001\u304a\u3088\u3073\u9055\u6cd5\u306a\u8a3c\u8a00\u3084\u6839\u62e0\u306e\u306a\u3044\u9069\u5fdc\u75c7\u3092\u542b\u3080\u3082\u306e\u3092\u7279\u5b9a\u3057\u307e\u3057\u305f\u3002\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u6d3b\u52d5\u306b\u306f\u3001\u672a\u627f\u8a8d\u306e\u6cbb\u7642\u7528\u5546\u54c1\u3001\u672a\u627f\u8a8d\u306e\u9069\u5fdc\u75c7\u304a\u3088\u3073\u4e3b\u5f35\u306e\u3042\u308b\u627f\u8a8d\u6e08\u307f\u6cbb\u7642\u7528\u5546\u54c1\u3001\u304a\u3088\u3073\u6cbb\u7642\u7528\u5546\u54c1\u5e83\u544a\u898f\u7d04\u306b\u6e96\u62e0\u3057\u3066\u3044\u306a\u3044\u9055\u6cd5\u306a\u8a3c\u8a00\u306e\u76e3\u8996\u304c\u542b\u307e\u308c\u307e\u3059\u3002\u91cd\u70b9\u5206\u91ce\u306f\u3001\u598a\u5a20\u3001\u7523\u524d\u30b1\u30a2\u3001\u6e1b\u91cf\u3001\u304a\u3088\u3073\u4e8c\u65e5\u9154\u3044\u6cbb\u7642\u3067\u3059\u3002<\/p>\n

    \u4eca\u5e74\u4e2d\u306b\u3055\u3089\u306a\u308b\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u512a\u5148\u5206\u91ce\u304c\u751f\u307e\u308c\u3001\u30ea\u30b9\u30c8\u306b\u8ffd\u52a0\u3055\u308c\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u512a\u5148\u5206\u91ce\u306f\u3001\u88dc\u5b8c\u533b\u7642\u30ea\u30b9\u30c8 (\u5e02\u8ca9\u5f8c\u30ec\u30d3\u30e5\u30fc)\u3001\u533b\u7642\u6a5f\u5668\u542b\u6709\u7269\u306e\u76e3\u8996\u3068\u76e3\u8996\u3001\u533b\u85ac\u54c1\u5b89\u5168\u6027\u76e3\u8996\u304a\u3088\u3073\u9069\u6b63\u81e8\u5e8a\u5b9f\u65bd\u57fa\u6e96\u691c\u67fb\u30d7\u30ed\u30b0\u30e9\u30e0\u3001\u304a\u3088\u3073 GMP \u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9 \u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u95a2\u3059\u308b\u901a\u5e38\u306e TGA \u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9 \u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u8ffd\u52a0\u3055\u308c\u308b\u3082\u306e\u3067\u3059\u3002<\/p>\n

    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n
    \n

    \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u306e\u898f\u5236\u5909\u66f4\u306e\u8a73\u7d30\u306b\u3064\u3044\u3066\u306f\u3001RegASK \u306b\u304a\u554f\u3044\u5408\u308f\u305b\u304f\u3060\u3055\u3044\u3002\u00a0<\/a><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\t\t\u8a73\u7d30\u306b\u3064\u3044\u3066\u306fRegASK\u306b\u304a\u554f\u3044\u5408\u308f\u305b\u304f\u3060\u3055\u3044<\/span>\n\t<\/a>\n\n\n\t\t\u7d9a\u304d\u3092\u8aad\u3080<\/span>\n\t<\/a>\n\n

    \n\n\t
    \n\t\t\t\t
    \n\t\t\t\n\t\t\t\n\n\t\t\u88fd\u85ac\u304a\u3088\u3073\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u696d\u754c\u306e\u30b1\u30fc\u30b9\u30b9\u30bf\u30c7\u30a3\u3092\u8aad\u3080<\/span>\n\t<\/a>\n\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\n\t\n<\/div>\n
    \n
    \n
    <\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"

    The TGA has published a list of import, advertising, and supply compliance priorities from I July 2022 to 30 June 2023: Deter and address the unlawful import, advertising, and supply of unapproved therapeutic goods associated with COVID-19. Disrupt and address the unlawful import, advertising, and supply of nicotine vaping products. Ensure compliance with the requirements of the Therapeutic Goods Act 1989 across the\u00a0medicinal cannabis industry Disrupt and address the unlawful import, manufacture, advertising, and supply of unapproved performance and image-enhancing therapeutic goods, including sports supplements, with a focus on products containing schedule 4 and 8 poisons. Deter and address the unlawful import, advertising, and supply of unapproved therapeutic goods used…<\/p>","protected":false},"author":39,"featured_media":2487,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[511,35],"tags":[40],"class_list":["post-3764","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-australia-regulations","category-pharma-biotech-latest-insights","tag-latest-insights"],"acf":[],"yoast_head":"\nAustralia: Import, Ads & Supply Compliance Priorities 2022 | RegASK<\/title>\n<meta name=\"description\" content=\"Australia's TGA has published a list of import, advertising and supply compliance priorities from I July 2022 to 30 June 2023.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/ja\/\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u306e\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u512a\u5148\u4e8b\u9805-2022\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Australia: Import, Advertising and Supply Compliance Priorities 2022-23\" \/>\n<meta property=\"og:description\" content=\"Australia's TGA has published a list of import, advertising and supply compliance priorities from I July 2022 to 30 June 2023.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/ja\/\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u306e\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u512a\u5148\u4e8b\u9805-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-02T01:30:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-24T16:45:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills.png\" \/>\n\t<meta property=\"og:image:width\" content=\"689\" \/>\n\t<meta property=\"og:image:height\" content=\"626\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Benoit Trouwaert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Benoit Trouwaert\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/\"},\"author\":{\"name\":\"Benoit Trouwaert\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\"},\"headline\":\"Australia: Import, Advertising and Supply Compliance Pr…\",\"datePublished\":\"2022-08-02T01:30:47+00:00\",\"dateModified\":\"2024-10-24T16:45:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/\"},\"wordCount\":444,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/pharma-pills.png\",\"keywords\":[\"Latest Insights\"],\"articleSection\":[\"Australia\",\"Pharma and Biotech\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/\",\"name\":\"Australia: Import, Ads & Supply Compliance Priorities 2022 | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/pharma-pills.png\",\"datePublished\":\"2022-08-02T01:30:47+00:00\",\"dateModified\":\"2024-10-24T16:45:40+00:00\",\"description\":\"Australia's TGA has published a list of import, advertising and supply compliance priorities from I July 2022 to 30 June 2023.\",\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/regask.com\\\/australia-compliance-priorities-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/pharma-pills.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2021\\\/04\\\/pharma-pills.png\",\"width\":689,\"height\":626,\"caption\":\"Medication tablets\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/c1d261e8dcf7b1c30b2c4f2c119df42d\",\"name\":\"Benoit Trouwaert\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2: \u8f38\u5165\u3001\u5e83\u544a\u3001\u4f9b\u7d66\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u306e\u512a\u5148\u4e8b\u9805 2022 | RegASK","description":"\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u306eTGA\u306f\u30012022\u5e747\u67081\u65e5\u304b\u30892023\u5e746\u670830\u65e5\u307e\u3067\u306e\u8f38\u5165\u3001\u5e83\u544a\u3001\u4f9b\u7d66\u306e\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u512a\u5148\u4e8b\u9805\u306e\u30ea\u30b9\u30c8\u3092\u516c\u958b\u3057\u307e\u3057\u305f\u3002","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/ja\/\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u306e\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u512a\u5148\u4e8b\u9805-2022\/","og_locale":"ja_JP","og_type":"article","og_title":"Australia: Import, Advertising and Supply Compliance Priorities 2022-23","og_description":"Australia's TGA has published a list of import, advertising and supply compliance priorities from I July 2022 to 30 June 2023.","og_url":"https:\/\/regask.com\/ja\/\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u306e\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u512a\u5148\u4e8b\u9805-2022\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2022-08-02T01:30:47+00:00","article_modified_time":"2024-10-24T16:45:40+00:00","og_image":[{"width":689,"height":626,"url":"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills.png","type":"image\/png"}],"author":"Benoit Trouwaert","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"\u57f7\u7b46\u8005":"Benoit Trouwaert","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/#article","isPartOf":{"@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/"},"author":{"name":"Benoit Trouwaert","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d"},"headline":"Australia: Import, Advertising and Supply Compliance Pr…","datePublished":"2022-08-02T01:30:47+00:00","dateModified":"2024-10-24T16:45:40+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/"},"wordCount":444,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills.png","keywords":["Latest Insights"],"articleSection":["Australia","Pharma and Biotech"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/","url":"https:\/\/regask.com\/australia-compliance-priorities-2022\/","name":"\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2: \u8f38\u5165\u3001\u5e83\u544a\u3001\u4f9b\u7d66\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u306e\u512a\u5148\u4e8b\u9805 2022 | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills.png","datePublished":"2022-08-02T01:30:47+00:00","dateModified":"2024-10-24T16:45:40+00:00","description":"\u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2\u306eTGA\u306f\u30012022\u5e747\u67081\u65e5\u304b\u30892023\u5e746\u670830\u65e5\u307e\u3067\u306e\u8f38\u5165\u3001\u5e83\u544a\u3001\u4f9b\u7d66\u306e\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u512a\u5148\u4e8b\u9805\u306e\u30ea\u30b9\u30c8\u3092\u516c\u958b\u3057\u307e\u3057\u305f\u3002","inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/australia-compliance-priorities-2022\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/regask.com\/australia-compliance-priorities-2022\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2021\/04\/pharma-pills.png","width":689,"height":626,"caption":"Medication tablets"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"\u3088\u308a\u30b9\u30de\u30fc\u30c8\u306a\u898f\u5236\u6c7a\u5b9a\u3092\u4fc3\u9032","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/c1d261e8dcf7b1c30b2c4f2c119df42d","name":"\u30d6\u30ce\u30ef\u30fb\u30c8\u30a5\u30eb\u30ef\u30fc\u30eb"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/posts\/3764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/users\/39"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/comments?post=3764"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/posts\/3764\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/media\/2487"}],"wp:attachment":[{"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/media?parent=3764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/categories?post=3764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/ja\/wp-json\/wp\/v2\/tags?post=3764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}